Copertina

Review Article: Individualised Management of Reflux‐Like Symptoms—Strategies Beyond Acid Suppression

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Peter J. Kahrilas, Laurie Keefer, Rena Yadlapati, Foteini Anastasiou, Joel J. Heidelbaugh, Colin W. Howden, Juan M. Mendive, Edoardo Vincenzo Savarino, Mihaela Udrescu, A. Pali S. Hungin
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Alimentary Pharmacology & Therapeutics
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Editorial: The Milan Score as Supportive Evidence of Gastro‐Oesophageal Reflux Disease
di: Javier Chahuán, et al.
Pubblicazione: (2026)

Review article: Diagnosis and management of laryngopharyngeal reflux
di: Amanda J. Krause, et al.
Pubblicazione: (2024)

Letter: The Persistence of Anxiety and Depression in Inflammatory Bowel Disease: A Core Phenotype Beyond Inflammatory Activity
di: Brigida Barberio, et al.
Pubblicazione: (2026)

Letter: Unlocking the Full Potential of Dietary Therapy in IBD —The Case for Universal Eating Disorder Screening
di: Luisa Bertin, et al.
Pubblicazione: (2026)

Letter: Double‐Dose Hepatitis B Vaccination in IBD —A Step Forward in Protecting Immunosuppressed Patients
di: Luisa Bertin, et al.
Pubblicazione: (2026)

Letter: Gastroparesis in Lung Transplantation: Time to Reframe and Standardise Post‐Transplant Foregut Motility Evaluation
di: Luisa Bertin, et al.
Pubblicazione: (2026)

Letter: Rifaximin Versus Low FODMAP Diet in IBS : What the Primary Endpoint Does Not Tell Us
di: Luisa Bertin, et al.
Pubblicazione: (2026)

Editorial: Toward Safer Pain Management in IBD—Lessons From Prescription Patterns
di: Shabari Shenoy, et al.
Pubblicazione: (2025)

Editorial: Food for Thought—Addressing the Nuances of Diet and Mood When Evaluating Dietary Intervention in IBS
di: Cecilia Katzenstein, et al.
Pubblicazione: (2024)

Letter: Peripheral Eosinophilia Does Not Correlate With Endoscopic and Histological Activity in Paediatric Eosinophilic Oesophagitis. Authors' Reply
di: Pierfrancesco Visaggi, et al.
Pubblicazione: (2026)

Integrated Analysis of Vonoprazan Safety for Symptomatic Gastro‐Oesophageal Reflux Disease or Erosive Oesophagitis
di: Colin W. Howden, et al.
Pubblicazione: (2024)

A Message From the Editors
di: Colin W. Howden, et al.
Pubblicazione: (2024)

Use of a Non‐Endoscopic Capsule‐Sponge Triage Test for Reflux Symptoms: Results From the NHS England Prospective Real‐World Evaluation
di: Vlasios Gourgiotis, et al.
Pubblicazione: (2025)

Applying Lyon consensus criteria in the work‐up of patients with extra‐oesophageal symptoms – A multicentre retrospective study
di: Francesco Calabrese, et al.
Pubblicazione: (2024)

Editorial: Diagnosis of GERD in patients with extra‐oesophageal symptoms—still a long way to go… Authors' reply'
di: Francesco Calabrese, et al.
Pubblicazione: (2024)

Letter: Prospective Individualised Validation of the GES in Predicting Hepatocellular Carcinoma—A ‘Precision Medicine’ Study
di: Ahmed Helmy
Pubblicazione: (2025)

Letter: Prospective Individualised Validation of the GES in Predicting Hepatocellular Carcinoma—A ‘Precision Medicine’ Study: Authors' Reply
di: Gamal Shiha, et al.
Pubblicazione: (2025)

Letter: From Regional Diagnostic Thresholds to Phenotype‐Guided Management in Asian Reflux Disease
di: Jiahao Liu, et al.
Pubblicazione: (2026)

Editorial: The Milan Score as Supportive Evidence of Gastro‐Oesophageal Reflux Disease. Authors' Reply
di: Stefano Siboni, et al.
Pubblicazione: (2026)

Research Communication: Reflux Disease May Constitute a Risk Factor for Colonic Neoplasia
di: Amnon Sonnenberg, et al.
Pubblicazione: (2025)

Letter: H. pylori Infection May Constitute a Risk Factor for Reflux Disease and Colonic Neoplasia
di: Jannis Kountouras, et al.
Pubblicazione: (2025)

Letter: From Regional Diagnostic Thresholds to Phenotype‐Guided Management in Asian Reflux Disease. Authors' Reply
di: Walter W. Chan, et al.
Pubblicazione: (2026)

Editorial: When and What to Ask—Capturing the Symptoms Experienced by Patients With PSC. Authors' Reply
di: Natassia Tan, et al.
Pubblicazione: (2025)

Prevalence and Predictors of Symptoms of Anxiety or Depression at Diagnosis in Patients With Inflammatory Bowel Disease: An Inception Cohort
di: Christy Riggott, et al.
Pubblicazione: (2025)

Persistence of Symptoms of Anxiety and Depression in Inflammatory Bowel Disease: A Longitudinal Follow‐Up Study
di: Christy Riggott, et al.
Pubblicazione: (2025)

Review Article: Extending the Frontiers of Intestinal Ultrasound Knowledge, Performance and Expansion
di: Cathy Lu, et al.
Pubblicazione: (2025)

Blood Eosinophils Are Accurate Biomarkers for the Management of Eosinophilic Oesophagitis: Prospective, Multi‐Centre Study
di: Pierfrancesco Visaggi, et al.
Pubblicazione: (2026)

Review Article: Targeting Peroxisome Proliferator‐Activated Receptors in Primary Biliary Cholangitis
di: Jörn M. Schattenberg, et al.
Pubblicazione: (2026)

Review Article: Drug Approval for Gastroparesis—Suggestions for Improving the Process for Positive Results
di: Michael Camilleri, et al.
Pubblicazione: (2026)

Editorial for ‘Review Article: Extending the Frontiers of Intestinal Ultrasound Knowledge, Performance, and Expansion’
di: Cameron Kendall, et al.
Pubblicazione: (2025)

Review Article: The Evolving Role of GLP ‐1 Receptor Agonists in Gastroenterology Practice
di: Sydney Pomenti, et al.
Pubblicazione: (2025)

Review Article: Green Management of IBD—New Paradigms for an Eco‐Friendly Approach
di: Giovanni Cammarota, et al.
Pubblicazione: (2024)

Review Article: TL1A Inhibitors in IBD ‐ Mechanistic Rationale and Clinical Evidence
di: Manjeet Kumar Goyal, et al.
Pubblicazione: (2026)

Editorial: Upadacitinib—A Promising Induction Agent for Paediatric Crohn's Disease?
di: Vincenzo Stranges, et al.
Pubblicazione: (2025)

Review Article: Novel Enzyme Therapy Design for Gluten Peptide Digestion Through Exopeptidase Supplementation
di: Erin R. Bonner, et al.
Pubblicazione: (2025)

Review Article: Drug‐Induced Liver Injury Associated With Antibody‐Based Therapies in Haematologic Malignancies
di: Mengmeng Lin, et al.
Pubblicazione: (2025)

Review Article: Classic Bismuth Quadruple Therapy for Helicobacter pylori Infection—Questions Focused on Clinical Practice
di: Javier P. Gisbert, et al.
Pubblicazione: (2026)

Novel Symptom Subgroups in Patients With Irritable Bowel Syndrome Are Associated With Healthcare Utilisation in Secondary and Tertiary Care
di: Vivek C. Goodoory, et al.
Pubblicazione: (2026)

Editorial: When and What to Ask—Capturing the Symptoms Experienced by Patients With PSC
di: Christopher L. Bowlus, et al.
Pubblicazione: (2025)

Review Article: Surrogate Endpoints to Assess Treatment Efficacy in Disorders of Gut–Brain Interaction of Lower Gastrointestinal Tract
di: Michael Camilleri, et al.
Pubblicazione: (2025)